Related Experiment Video
Updated: May 19, 2026

Semi-Automated Analysis of Peak Amplitude and Latency for Auditory Brainstem Response Waveforms Using R
Published on: December 9, 2022
Auditory neuropathy in a low-risk population: a review of the literature
A M H Korver1, G A van Zanten, A Meuwese-Jongejeugd
1Willem-Alexander Children's Hospital, Sub Department of Social Pediatrics, Leiden University Medical Center, The Netherlands. a.m.h.korver@lumc.nl
Insights
Auditory neuropathy is missed in newborn hearing screenings using oto-acoustic emissions, contributing 4-17% to false negatives. More research is needed on auditory brainstem response screening effectiveness.
Area of Science:
- Neonatal screening
- Auditory health
- Neurology
Background:
- Auditory neuropathy (AN) is a hearing disorder affecting the auditory nerve.
- Newborn hearing screening programs aim to detect hearing loss early.
- Oto-acoustic emissions (OAEs) are commonly used in initial screening.
Purpose of the Study:
- To determine the prevalence of auditory neuropathy in well babies.
- To quantify the impact of auditory neuropathy on the false negative rate of OAE-based newborn hearing screening.
Main Methods:
- Systematic literature search of PubMed and EMBASE (1996-2010).
- Inclusion of original studies reporting AN prevalence in well infants.
- Analysis of data to calculate the false negative rate attributed to AN.
Main Results:
- Four studies met inclusion criteria.
- Prevalence of AN in screened infants ranged from 0.006% to 0.03%.
- AN accounted for 4-17% of false negatives in OAE-based screening.
Conclusions:
- Current data on AN prevalence in infants is limited.
- OAE screening may miss infants with auditory neuropathy.
- Cost-effectiveness of auditory brainstem response (ABR) screening warrants investigation.
Objective:
Collect all available published evidence on the prevalence of auditory neuropathy in the well baby population and calculate the contribution of this to the false negative rate of oto-acoustic emission based newborn hearing screening programs.
Method:
PubMed and EMBASE were searched for relevant articles published between 1996 and 2010. Medical Subject Headings terms included 'Auditory disease', 'Prevalence' and 'Child' and their relevant synonyms. Included were original studies, which focused on well babies and reported the prevalence of auditory neuropathy.
Results:
Of 519 citations 4 articles met the inclusion criteria. The population based prevalence of auditory neuropathy in children in population hearing screening was found to vary between 0.006% (SD 0.006) and 0.03% (SD 0.02). The false negative rate, caused by missed children with auditory neuropathy, is between 4 and 17%.
Conclusion:
The available information on the prevalence of auditory neuropathy in the well baby population is poor. However, if oto-acoustic emission screening is used in the first stage of a neonatal hearing screening program, children with auditory neuropathy are missed. The cost-effectiveness of population-based screening using auditory brainstem response should be studied.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Neuropathy
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking the...

